Carbenicillin is an established antibiotic for infections due to two difficult groups of organisms-Ps. aeruginosa and the indolepositive Proteus spp.4 Non-,3-lactamase-producing E. coli are very susceptible to carbenicillin and Str. faecalis moderately so. Though carbenicillin is particularly useful against Ps. aeruginosa high parenteral doses (up to 30 g/day) may be needed to treat systemic infections with this organism. High urinary concentrations of carbenicillin have been reported,5 with intramuscular doses of 500 mg giving concentrations greater than 500 mg/l. Such levels will eradicate sensitive Ps. aeruginosa (M.I.C.< 100 mg/l) but the injections are often painful and the patient usually needs to be in hospital.
Discussion
Carbenicillin is an established antibiotic for infections due to two difficult groups of organisms-Ps. aeruginosa and the indolepositive Proteus spp.4 Non-,3-lactamase-producing E. coli are very susceptible to carbenicillin and Str. faecalis moderately so. Though carbenicillin is particularly useful against Ps. aeruginosa high parenteral doses (up to 30 g/day) may be needed to treat systemic infections with this organism. High urinary concentrations of carbenicillin have been reported,5 with intramuscular doses of 500 mg giving concentrations greater than 500 mg/l. Such levels will eradicate sensitive Ps. aeruginosa (M.I.C.< 100 mg/l) but the injections are often painful and the patient usually needs to be in hospital.
Serum levels in volunteers and patients after oral carfecillin were found to be insufficient to treat systemic infection with Ps. aeruginosa, even when renal function was impaired, but urinary levels were sufficient to suggest that urinary infections might be eradicated.
In severe renal failure the mean serum half life of carbenicillin is only [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] hours,2 which is short compared with that of gentamicin Lees and Harding'0 noted that 10-5% of patients who were given carfecillin capsules had diarrhoea, but only 4-35% who received the tablet form (as now marketed) complained of this side effect.
Our results compare favourably with those of Berrill et al,7
particularly as our dose was lower and given for seven days instead of 14. Our patients also had a high prevalence of urinary tract abnormalities. The overall cure rate with indanyl carbenicillin in the series of Ries et al. 9 was 50% as compared with 60% in our series, though no pseudomonas infections were treated with indanyl carbenicillin in the former series as compared with 12 in ours. Ps. aeruginosa rarely causes primary, uncomplicated urinary tract infection but it may cause infection secondary to other urinary tract conditions or operations where catheterization may have been necessary."' The only antibiotic therapy available to such patients is by the parenteral route, which usually means a stay in hospital. The availability of a well-tolerated oral agent for such cases represents a therapeutic advance. Further studies with carfecillin are necessary, and possibly a longer course of treatment should be given in difficult cases, but this drug promises to be a useful oral treatment of urinary infections when the choice of effective antibiotics is limited.
The formulation of carfecillin to be marketed in the United Kingdom will differ slightly from that used in our studies reported here, the main change being improved oral absorption. 3 Its performance in curing infection will probably be at least as good as that of the previous formulation, but side effects and tolerability will need to be reassessed.
Introduction
Renal injury in most patients with Goodpasture's syndrome is known to be mediated by antibodies directed at the glomerular basement membrance (G.B.M.).1-3 This syndrome-the association of lung haemorrhage and glomerulonephritis-is characterized by a rapidly fatal course terminating in renal failure or asphyxia from uncontrolled lung haemorrhage. Since damage to the kidney and probably also to the lungs is mediated by antibody to their basement membranes3 immunosuppressive therapy with steroids and cytotoxic drugs seems logical but has generally been ineffective. We report here a patient in whom the combination of prednisolone and cyclophosphamide aimed at reducing antibody synthesis with plasmapheresis to remove circulating antibody was followed by reduction in circulating anti-G.B.M. antibody levels and substantial recovery from renal failure.
Case Report A 24-year-old man had been well until June 1974, when he was referred to hospital with a three-week history of streaky haemoptyses. He had had no exposure to drugs or toxic solvents. Apart from pallor and an apical systolic murmur physical examination showed nothing abnormal. Investigations showed: haemoglobin 8 g/dl, W.B.C. 8 x 101/1, serum iron 3-0 ,umol/l (17 ig/100 ml), serum iron binding capacity 818 ,umol/l (457 sig/100 ml), E.S.R. 25 mm in the first hour, blood urea 4 3 mmol/l (26 mg/100 ml), creatinine 79-6 iumol/l (0 9 mg 100 ml), and creatinine clearance 66 ml/min. Urine examination showed only occasional red cells and a trace of protein. Numerous haemosiderin-laden macrophages were found in the sputum on several occasions. Chest radiographs were normal. A renal biposy was performed, which on light microscopy showed 10 glomeruli. These were mostly normal but in two there was segmental proliferation with crescent formation and evidence of destruction of G. The patient was transferred to Hammersmith Hospital on 22 August, when his blood urea had risen to 18 3 mmol/l (110 mg/100 ml) and serum creatinine to 274 1mol/l (3 1 mg/100 ml). Creatinine clearance had fallen to 17 ml/min and the 24-hour urinary protein excretion was 4-2 g. Urine microscopy showed many red cells and occasional granular casts. Prednisolone was increased to 60 mg/day and cyclophosphamide 3 mg kg-' day-1 added. Aspirin 300 mg/day was also given to inhibit platelet stickiness. Heparin, 10 000 units every six hours intravenously, was given for seven days from 29 August. An arteriovenous silastic shunt was inserted and used both for haemodialysis and plasmapheresis. This procedure was carried out seven times over 25 days beginning on 6 September.
Initially renal function showed steady deterioration so that peritoneal dialysis and haemodialysis became necessary (see fig.) . There was no overt haemoptysis after the first week of steroid therapy but twice there were sudden falls in haemoglobin of about 4 g over 48 hours not associated with symptoms or overt signs of blood loss. After the first such fall a chest x-ray picture showed bilateral pulmonary infiltrates which cleared after six days. A second renal biopsy, which showed five glomeruli, was performed on 17 September. One 7 In a more recent study, in which the diagnosis was substantiated by the demonstration of circulating antibody to G.B.M. or elution of this antibody from the diseased kidney, only four out of 32 patients survived with good renal function, and only one of these had had renal failure requiring dialysis.8
Previous treatment of Goodpasture's syndrome has usually combined steroids with cytotoxic agents, but since there are no controlled studies conclusions about their value are limited. Growing evidence suggests that the generation of antibody to G.B.M. may be relatively short-lived, at least in some patients with this disease. Levels of anti-G.B.M. antibody can fall after bilateral nephrectomy, and, moreover, an increasing number of patients with Goodpasture's syndrome have been transplanted with no evidence of recurrent glomerular disease in the allotransplanted kidney.8 Thus, the therapeutic problem is to tide the patient with Goodpasture's syndrome over the period when the antibodies to basement membrane are being generated. In view of the apparent lack of success with immunosuppressive drugs alone it seemed logical to combine treatment with steroids and cyclophosphamide with the removal of circulating antibody by plasma exchange. The sequential measurement of antibody by radioimmunoassay confirmed the efficacy of plasmapheresis in removing autoantibody, and in our patient improvement in renal function occurred when circulating antibody was no longer detectable.
It was also apparent that antibody levels were falling before plasmapheresis was begun, and that the procedure only hastened removal of antibody from the extracellular fluid, though if the assay result had been immediately available plasma exchange could have been undertaken more often when antibody levels were high. Clearly, further experience is needed to determine whether the combination of plasmapheresis and cytotoxic therapy can maintain an effective reduction of antibody level in patients in the earlier stages of nephrotoxic antibody production.
Studies of glomerular injury by nephrotoxic antibody in animals have emphasized that fixation of antibody in excess of a "threshold" value is required before damage can be detected and that above this value there is a good correlation between injury and quantities of antibody administered.9 10 There is thus a rational basis for early and effective reduction in circulating antibody even if complete arrest of antibody synthesis cannot be achieved. Others have argued that continued generation of antibody in patients with Goodpasture's syndrome may be related to the release of glomerular basement antigens from the diseased kidney and have therefore advocated bilateral nephrectomy in patients with uncontrolled pulmonary haemorrhage."1 So far the results of this approach have been mixed: in some cases lung haemorrhage has stopped,'2 18 but in others this procedure has been followed by further pulmonary bleeding.'4 Intensive plasmapheresis combined with immunosuppressive drugs would certainly seem to be worth considering in any patient with life-threatening lung haemorrhage before submitting him or her to bilateral nephrectomy. (normal < 1%), serum creatinine to 238 ±mol/l (2-7 mg/ 100 ml), and the chest x-ray appearances had returned to normal. Plasmapheresis and immunosuppression are being continued until anti-G.B.M. antibody is no longer detectable.
SHORT REPORTS Epigastric Pain in Duodenal Ulcer
Some investigators have thought that pain in duodenal ulceration is due to the direct effect of acid on the ulcer.' Others have claimed that mobility of the gastroduodenal region is disturbed during pain., Nevertheless, when muscular activity of the gastroduodenal region was abolished without affecting the acidity, ulcer pain was not relieved. 3 Earlam has suggested that the pain arises from hypersensitivity of the lower oesophageal mucosa to acid." To test this hypothesis we have studied the gastro-oesophageal junction in 44 patients with proved duodenal ulceration.
Patients, Methods, and Results
Thirty-seven of 44 patients with radiologically and endoscopically proved duodenal ulcer (group A) had central epigastric pain, below the xiphisternum in the midline between the costal margins, and seven (group B) had nonepigastric pain. In all patients the function of the gastro-oesophageal junction was assessed by oesophageal manometry; acid infusion test; and radiography. Informed consent was obtained from all patients.
Patients in group A had a mean pressure of 13-1 mm ± 5-6 S.D., while those in group B had a mean of 13-0 mm ± 4-04 S.D. (see fig.) . During the acid infusion 12 experienced only retrosternal pain-nine in group A and three in group B. Another 12 complained of their usual epigastric pain and three of these experienced retrosternal pain. Any pain was abolished by 2-4% bicarbonate infusion of the oesophagus, but when 01 N HCI was reinfused the pain always returned. In ur of the 12 patients in whom acid infusion caused epigastric pain 200 ml of 2 4% bicarbonate solution was instilled into the stomach. When acid was reinfused into the oesophagus the Spipstric pam did not recur despite the infusion continuing for 30 minutes.
The remamiing 20 patients (16 in group A and four in group B) did not experience any pain during the acid infusion.
Nine patients in group A and two in group B had a relevant radiological abnormality of the gastro-oesophageal junction. 
Discussion

